View Financial HealthFuchs 配当と自社株買い配当金 基準チェック /36Fuchs配当を支払う会社であり、現在の利回りは3.28%で、収益によって十分にカバーされています。主要情報3.3%配当利回り0%バイバック利回り総株主利回り3.3%将来の配当利回り3.8%配当成長3.7%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向53%最近の配当と自社株買いの更新お知らせ • Mar 23Fuchs SE Proposes Dividend for the Year 2024Fuchs SE proposed to the annual general meeting a dividend increase by 5%, to EUR 1.16 (EUR 1.10) per ordinary share for the year 2024.Upcoming Dividend • Apr 27Upcoming dividend of €1.07 per share at 2.9% yieldEligible shareholders must have bought the stock before 04 May 2023. Payment date: 08 May 2023. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.9%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.3%).Upcoming Dividend • Apr 27Upcoming dividend of €1.03 per shareEligible shareholders must have bought the stock before 04 May 2022. Payment date: 06 May 2022. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 3.4%. Lower than top quartile of British dividend payers (4.6%). Higher than average of industry peers (2.7%).Upcoming Dividend • Apr 28Upcoming dividend of €0.99 per shareEligible shareholders must have bought the stock before 05 May 2021. Payment date: 07 May 2021. Trailing yield: 2.2%. Lower than top quartile of British dividend payers (4.1%). Higher than average of industry peers (1.6%).すべての更新を表示Recent updatesお知らせ • Mar 26+ 1 more updateFuchs SE, Annual General Meeting, May 06, 2026Fuchs SE, Annual General Meeting, May 06, 2026, at 10:00 W. Europe Standard Time.お知らせ • Jan 27+ 1 more updateFuchs SE to Report Q3, 2026 Results on Oct 30, 2026Fuchs SE announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Oct 30, 2026お知らせ • May 02Fuchs SE Reaffirms Earnings Guidance for the Year 2025Fuchs SE reaffirmed earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.お知らせ • Mar 27Fuchs SE, Annual General Meeting, May 07, 2025Fuchs SE, Annual General Meeting, May 07, 2025, at 10:00 W. Europe Standard Time.お知らせ • Mar 23Fuchs SE Proposes Dividend for the Year 2024Fuchs SE proposed to the annual general meeting a dividend increase by 5%, to EUR 1.16 (EUR 1.10) per ordinary share for the year 2024.お知らせ • Mar 22Fuchs SE Provides Earnings Guidance for the Year 2025Fuchs SE provided earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.Reported Earnings • Nov 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: €902.0m (up 3.0% from 3Q 2023). Net income: €80.0m (up 3.9% from 3Q 2023). Profit margin: 8.9% (up from 8.8% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 6.2% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Oct 16+ 2 more updatesFuchs SE to Report Q1, 2025 Final Results on Apr 30, 2025Fuchs SE announced that they will report Q1, 2025 final results on Apr 30, 2025お知らせ • Sep 13Fuchs SE (XTRA:FPE3) signed a letter of intent to acquire Strub & Co. Ag.Fuchs SE (XTRA:FPE3) signed a letter of intent to acquire Strub & Co. Ag on September 13, 2024. For the period ending December 31, 2023, Strub & Co. Ag reported total revenue of €15 million. The transaction to be completed by the end of 2024.お知らせ • Aug 29Fuchs SE to Report Fiscal Year 2024 Results on Mar 21, 2025Fuchs SE announced that they will report fiscal year 2024 results on Mar 21, 2025Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: €0.59 (vs €0.50 in 2Q 2023)Second quarter 2024 results: EPS: €0.59 (up from €0.50 in 2Q 2023). Revenue: €887.0m (flat on 2Q 2023). Net income: €78.0m (up 15% from 2Q 2023). Profit margin: 8.8% (up from 7.7% in 2Q 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Reported Earnings • May 01First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: €877.0m (down 6.3% from 1Q 2023). Net income: €77.0m (up 5.5% from 1Q 2023). Profit margin: 8.8% (up from 7.8% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 2.7% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Apr 24Fuchs SE (XTRA:FPE3) signed an agreement to acquire Lubricant Consult Gmbh (Gesellschaft FÜR Schmier- Und GrenzflÄChenaktive Stoffe).Fuchs SE (XTRA:FPE3) signed an agreement to acquire Lubricant Consult Gmbh (Gesellschaft FÜR Schmier- Und GrenzflÄChenaktive Stoffe) on April 22, 2024. As of financial year 2023, Lubricant Consult reported a sales revenue of €40 million. The transaction is subject to approval from the cartel authorities and is expected to close in the third quarter of 2024.Reported Earnings • Mar 13Full year 2023 earnings releasedFull year 2023 results: Revenue: €3.54b (up 3.8% from FY 2022). Net income: €282.0m (up 8.9% from FY 2022). Profit margin: 8.0% (up from 7.6% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 3.9% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Dec 08Fuchs SE Appoints Dr. Timo Reister as Deputy Chairman of the Executive BoardThe Supervisory Board of FUCHS SE has appointed Dr. Timo Reister (44) as Deputy Chairman of the Executive Board. The appointment will take effect from January 1, 2024 and is part of the company's long-term succession planning. Timo Reister joined FUCHS in 2009 after studying business administration and completing his doctorate and has been a member of the Executive Board based in Mannheim since 2016. After joining the company, he was responsible for the OEM and specialty business in the USA as well as for FUCHS Mexico for almost five years. He then moved to China in 2014, where he headed the Asia-Pacific region as a member of the Group Management Committee. Through these stays, Timo Reister got to know FUCHS' two most important foreign markets on the ground. At present, he is responsible for the two global regions Americas and Asia-Pacific as well as for three global sales divisions: OEM, Automotive Aftermarket and Mining. The responsibilities of the Executive Board remain unchanged by this appointment. In addition to Stefan FUCHS (55) and Dr. Timo Reister (44), the at the end of 2022 newly formed Executive Board team consists of Isabelle Adelt (39), CFO, Dr. Sebastian Heiner (45), CTO, and Dr. Ralph Rheinboldt responsible for the EMEA region (Europe, Africa and Middle East) and the Industry and Specialties divisions.Reported Earnings • Oct 28Third quarter 2023 earnings releasedThird quarter 2023 results: EPS: €0.57. Revenue: €876.0m (down 2.9% from 3Q 2022). Net income: €77.0m (up 10.0% from 3Q 2022). Profit margin: 8.8% (up from 7.8% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Buying Opportunity • Oct 26Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.2%. The fair value is estimated to be €43.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 8.5%. Revenue is forecast to grow by 3.6% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.お知らせ • Oct 24+ 3 more updatesFuchs SE, Annual General Meeting, May 08, 2024Fuchs SE, Annual General Meeting, May 08, 2024.お知らせ • Sep 12Fuchs SE to Report Fiscal Year 2023 Results on Mar 12, 2024Fuchs SE announced that they will report fiscal year 2023 results Pre-Market on Mar 12, 2024お知らせ • Sep 05Fuchs SE (XTRA:FPE3) acquired the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda..Fuchs SE (XTRA:FPE3) acquired the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda. on September 1, 2023. Fuchs SE (XTRA:FPE3) completed the acquisition of the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda. on September 1, 2023.Reported Earnings • Jul 30Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: €886.0m (up 6.5% from 2Q 2022). Net income: €68.0m (up 12% from 2Q 2022). Profit margin: 7.7% (up from 7.3% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 5.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Upcoming Dividend • Apr 27Upcoming dividend of €1.07 per share at 2.9% yieldEligible shareholders must have bought the stock before 04 May 2023. Payment date: 08 May 2023. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.9%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.3%).Reported Earnings • Mar 09Full year 2022 earnings released: EPS: €1.87 (vs €1.82 in FY 2021)Full year 2022 results: EPS: €1.87 (up from €1.82 in FY 2021). Revenue: €3.41b (up 19% from FY 2021). Net income: €259.0m (up 2.4% from FY 2021). Profit margin: 7.6% (down from 8.8% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 1.5% growth forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 8% per year and the company’s share price has also increased by 8% per year.お知らせ • Jan 02+ 3 more updatesFuchs Petrolub SE, Annual General Meeting, May 03, 2023Fuchs Petrolub SE, Annual General Meeting, May 03, 2023.Reported Earnings • Oct 30Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: €902.0m (up 26% from 3Q 2021). Net income: €70.0m (up 15% from 3Q 2021). Profit margin: 7.8% (down from 8.5% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 8.6% decline forecast for the Chemicals industry in the United Kingdom.お知らせ • Oct 25Fuchs Petrolub SE to Report Fiscal Year 2022 Results on Mar 08, 2023Fuchs Petrolub SE announced that they will report fiscal year 2022 results on Mar 08, 2023Valuation Update With 7 Day Price Move • Sep 29Investor sentiment improved over the past weekAfter last week's 65% share price gain to €43.87, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 44% over the past three years.Valuation Update With 7 Day Price Move • Sep 14Investor sentiment improved over the past weekAfter last week's 60% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 36% over the past three years.Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 59% share price gain to €43.87, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 50% over the past three years.Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improved over the past weekAfter last week's 54% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 49% over the past three years.Reported Earnings • Aug 01Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: €832.0m (up 17% from 2Q 2021). Net income: €61.0m (down 6.2% from 2Q 2021). Profit margin: 7.3% (down from 9.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 4.7% compared to a 20% decline forecast for the industry in the United Kingdom.Valuation Update With 7 Day Price Move • Jul 27Investor sentiment improved over the past weekAfter last week's 52% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 35% over the past three years.Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improved over the past weekAfter last week's 63% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €80.44 per share.Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 75% share price gain to €43.87, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €84.69 per share.Valuation Update With 7 Day Price Move • Jun 10Investor sentiment improved over the past weekAfter last week's 50% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €74.01 per share.Valuation Update With 7 Day Price Move • May 26Investor sentiment improved over the past weekAfter last week's 59% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 34% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €77.33 per share.Valuation Update With 7 Day Price Move • May 06Investor sentiment improved over the past weekAfter last week's 46% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 33% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €77.38 per share.Reported Earnings • May 01First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: €808.0m (up 16% from 1Q 2021). Net income: €67.0m (down 5.6% from 1Q 2021). Profit margin: 8.3% (down from 10% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 6.9% compared to a 16% decline forecast for the industry in the United Kingdom.Upcoming Dividend • Apr 27Upcoming dividend of €1.03 per shareEligible shareholders must have bought the stock before 04 May 2022. Payment date: 06 May 2022. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 3.4%. Lower than top quartile of British dividend payers (4.6%). Higher than average of industry peers (2.7%).Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improved over the past weekAfter last week's 32% share price gain to €43.87, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €62.33 per share.Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 39% share price gain to €43.87, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €71.38 per share.Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 21% share price gain to €43.87, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 19% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €65.29 per share.Valuation Update With 7 Day Price Move • Feb 14Investor sentiment improved over the past weekAfter last week's 15% share price gain to €43.87, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 21x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 14% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €61.71 per share.Valuation Update With 7 Day Price Move • Jan 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to €43.87, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 22x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 15% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €60.27 per share.Reported Earnings • Nov 03Third quarter 2021 earnings released: EPS €0.44The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: €718.0m (up 16% from 3Q 2020). Net income: €61.0m (down 3.2% from 3Q 2020). Profit margin: 8.5% (down from 10% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 2% per year.Valuation Update With 7 Day Price Move • Oct 12Investor sentiment improved over the past weekAfter last week's 15% share price gain to €43.87, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 24x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 2.4% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €61.82 per share.Reported Earnings • Aug 01Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €714.0m (up 42% from 2Q 2020). Net income: €65.0m (up 132% from 2Q 2020). Profit margin: 9.1% (up from 5.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 5% per year.Reported Earnings • May 04First quarter 2021 earnings releasedThe company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €697.0m (up 13% from 1Q 2020). Net income: €71.0m (up 39% from 1Q 2020). Profit margin: 10% (up from 8.3% in 1Q 2020). The increase in margin was driven by higher revenue.Upcoming Dividend • Apr 28Upcoming dividend of €0.99 per shareEligible shareholders must have bought the stock before 05 May 2021. Payment date: 07 May 2021. Trailing yield: 2.2%. Lower than top quartile of British dividend payers (4.1%). Higher than average of industry peers (1.6%).Reported Earnings • Mar 10Full year 2020 earnings released: EPS €1.58 (vs €1.64 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: €2.38b (down 7.5% from FY 2019). Net income: €220.0m (down 3.5% from FY 2019). Profit margin: 9.3% (up from 8.9% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Analyst Estimate Surprise Post Earnings • Mar 10Revenue beats expectationsRevenue exceeded analyst estimates by 0.1%. Over the next year, revenue is forecast to grow 8.6% compared to a 9.5% decline forecast for the Chemicals industry in the United Kingdom.Is New 90 Day High Low • Feb 26New 90-day low: €45.38The company is down 6.0% from its price of €48.16 on 27 November 2020. The British market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €42.92 per share.Is New 90 Day High Low • Feb 08New 90-day high: €49.44The company is up 6.0% from its price of €46.68 on 10 November 2020. The British market is also up 6.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €44.43 per share.Is New 90 Day High Low • Nov 11New 90-day high: €47.62The company is up 24% from its price of €38.30 on 13 August 2020. The British market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.96 per share.Analyst Estimate Surprise Post Earnings • Nov 05Revenue beats expectationsRevenue exceeded analyst estimates by 14%. Over the next year, revenue is forecast to grow 4.2% compared to a 14% decline forecast for the Chemicals industry in the United Kingdom.Is New 90 Day High Low • Oct 17New 90-day high: €45.98The company is up 20% from its price of €38.16 on 17 July 2020. The British market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €40.29 per share.Is New 90 Day High Low • Sep 29New 90-day high: €42.62The company is up 19% from its price of €35.72 on 01 July 2020. The British market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.66 per share.決済の安定と成長配当データの取得安定した配当: 配当金の支払いは安定していますが、 0LCRが配当金を支払っている期間は 10 年未満です。増加する配当: 0LCRの配当金は増加していますが、同社は9年間しか配当金を支払っていません。配当利回り対市場Fuchs 配当利回り対市場0LCR 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (0LCR)3.3%市場下位25% (GB)2.2%市場トップ25% (GB)5.6%業界平均 (Chemicals)3.7%アナリスト予想 (0LCR) (最長3年)3.8%注目すべき配当: 0LCRの配当金 ( 3.28% ) はUK市場の配当金支払者の下位 25% ( 2.23% ) よりも高くなっています。高配当: 0LCRの配当金 ( 3.28% ) はUK市場の配当金支払者の上位 25% ( 5.64% ) と比較すると低いです。株主への利益配当収益カバレッジ: 0LCRの配当金は、合理的な 配当性向 ( 52.7% ) により、利益によって賄われています。株主配当金キャッシュフローカバレッジ: 0LCRの 現金配当性向 ( 47% ) は比較的低く、配当金の支払いはキャッシュフローによって十分にカバーされています。高配当企業の発掘7D1Y7D1Y7D1YGB 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 15:48終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Fuchs SE 10 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。28 アナリスト機関Konstantin WiechertBaader Helvea Equity ResearchVolker BosseBaader Helvea Equity ResearchAnil ShenoyBarclays25 その他のアナリストを表示
お知らせ • Mar 23Fuchs SE Proposes Dividend for the Year 2024Fuchs SE proposed to the annual general meeting a dividend increase by 5%, to EUR 1.16 (EUR 1.10) per ordinary share for the year 2024.
Upcoming Dividend • Apr 27Upcoming dividend of €1.07 per share at 2.9% yieldEligible shareholders must have bought the stock before 04 May 2023. Payment date: 08 May 2023. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.9%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.3%).
Upcoming Dividend • Apr 27Upcoming dividend of €1.03 per shareEligible shareholders must have bought the stock before 04 May 2022. Payment date: 06 May 2022. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 3.4%. Lower than top quartile of British dividend payers (4.6%). Higher than average of industry peers (2.7%).
Upcoming Dividend • Apr 28Upcoming dividend of €0.99 per shareEligible shareholders must have bought the stock before 05 May 2021. Payment date: 07 May 2021. Trailing yield: 2.2%. Lower than top quartile of British dividend payers (4.1%). Higher than average of industry peers (1.6%).
お知らせ • Mar 26+ 1 more updateFuchs SE, Annual General Meeting, May 06, 2026Fuchs SE, Annual General Meeting, May 06, 2026, at 10:00 W. Europe Standard Time.
お知らせ • Jan 27+ 1 more updateFuchs SE to Report Q3, 2026 Results on Oct 30, 2026Fuchs SE announced that they will report Q3, 2026 results at 7:00 AM, Central European Standard Time on Oct 30, 2026
お知らせ • May 02Fuchs SE Reaffirms Earnings Guidance for the Year 2025Fuchs SE reaffirmed earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.
お知らせ • Mar 27Fuchs SE, Annual General Meeting, May 07, 2025Fuchs SE, Annual General Meeting, May 07, 2025, at 10:00 W. Europe Standard Time.
お知らせ • Mar 23Fuchs SE Proposes Dividend for the Year 2024Fuchs SE proposed to the annual general meeting a dividend increase by 5%, to EUR 1.16 (EUR 1.10) per ordinary share for the year 2024.
お知らせ • Mar 22Fuchs SE Provides Earnings Guidance for the Year 2025Fuchs SE provided earnings guidance for the year 2025. For the year, the company expects sales revenues around EUR 3.7 billion and EBIT around EUR 460 million.
Reported Earnings • Nov 01Third quarter 2024 earnings releasedThird quarter 2024 results: Revenue: €902.0m (up 3.0% from 3Q 2023). Net income: €80.0m (up 3.9% from 3Q 2023). Profit margin: 8.9% (up from 8.8% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 6.2% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Oct 16+ 2 more updatesFuchs SE to Report Q1, 2025 Final Results on Apr 30, 2025Fuchs SE announced that they will report Q1, 2025 final results on Apr 30, 2025
お知らせ • Sep 13Fuchs SE (XTRA:FPE3) signed a letter of intent to acquire Strub & Co. Ag.Fuchs SE (XTRA:FPE3) signed a letter of intent to acquire Strub & Co. Ag on September 13, 2024. For the period ending December 31, 2023, Strub & Co. Ag reported total revenue of €15 million. The transaction to be completed by the end of 2024.
お知らせ • Aug 29Fuchs SE to Report Fiscal Year 2024 Results on Mar 21, 2025Fuchs SE announced that they will report fiscal year 2024 results on Mar 21, 2025
Reported Earnings • Aug 01Second quarter 2024 earnings released: EPS: €0.59 (vs €0.50 in 2Q 2023)Second quarter 2024 results: EPS: €0.59 (up from €0.50 in 2Q 2023). Revenue: €887.0m (flat on 2Q 2023). Net income: €78.0m (up 15% from 2Q 2023). Profit margin: 8.8% (up from 7.7% in 2Q 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • May 01First quarter 2024 earnings releasedFirst quarter 2024 results: Revenue: €877.0m (down 6.3% from 1Q 2023). Net income: €77.0m (up 5.5% from 1Q 2023). Profit margin: 8.8% (up from 7.8% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 3.8% p.a. on average during the next 3 years, compared to a 2.7% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Apr 24Fuchs SE (XTRA:FPE3) signed an agreement to acquire Lubricant Consult Gmbh (Gesellschaft FÜR Schmier- Und GrenzflÄChenaktive Stoffe).Fuchs SE (XTRA:FPE3) signed an agreement to acquire Lubricant Consult Gmbh (Gesellschaft FÜR Schmier- Und GrenzflÄChenaktive Stoffe) on April 22, 2024. As of financial year 2023, Lubricant Consult reported a sales revenue of €40 million. The transaction is subject to approval from the cartel authorities and is expected to close in the third quarter of 2024.
Reported Earnings • Mar 13Full year 2023 earnings releasedFull year 2023 results: Revenue: €3.54b (up 3.8% from FY 2022). Net income: €282.0m (up 8.9% from FY 2022). Profit margin: 8.0% (up from 7.6% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 3.9% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Dec 08Fuchs SE Appoints Dr. Timo Reister as Deputy Chairman of the Executive BoardThe Supervisory Board of FUCHS SE has appointed Dr. Timo Reister (44) as Deputy Chairman of the Executive Board. The appointment will take effect from January 1, 2024 and is part of the company's long-term succession planning. Timo Reister joined FUCHS in 2009 after studying business administration and completing his doctorate and has been a member of the Executive Board based in Mannheim since 2016. After joining the company, he was responsible for the OEM and specialty business in the USA as well as for FUCHS Mexico for almost five years. He then moved to China in 2014, where he headed the Asia-Pacific region as a member of the Group Management Committee. Through these stays, Timo Reister got to know FUCHS' two most important foreign markets on the ground. At present, he is responsible for the two global regions Americas and Asia-Pacific as well as for three global sales divisions: OEM, Automotive Aftermarket and Mining. The responsibilities of the Executive Board remain unchanged by this appointment. In addition to Stefan FUCHS (55) and Dr. Timo Reister (44), the at the end of 2022 newly formed Executive Board team consists of Isabelle Adelt (39), CFO, Dr. Sebastian Heiner (45), CTO, and Dr. Ralph Rheinboldt responsible for the EMEA region (Europe, Africa and Middle East) and the Industry and Specialties divisions.
Reported Earnings • Oct 28Third quarter 2023 earnings releasedThird quarter 2023 results: EPS: €0.57. Revenue: €876.0m (down 2.9% from 3Q 2022). Net income: €77.0m (up 10.0% from 3Q 2022). Profit margin: 8.8% (up from 7.8% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 5.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Buying Opportunity • Oct 26Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.2%. The fair value is estimated to be €43.46, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 16% over the last 3 years. Earnings per share has grown by 8.5%. Revenue is forecast to grow by 3.6% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.
お知らせ • Oct 24+ 3 more updatesFuchs SE, Annual General Meeting, May 08, 2024Fuchs SE, Annual General Meeting, May 08, 2024.
お知らせ • Sep 12Fuchs SE to Report Fiscal Year 2023 Results on Mar 12, 2024Fuchs SE announced that they will report fiscal year 2023 results Pre-Market on Mar 12, 2024
お知らせ • Sep 05Fuchs SE (XTRA:FPE3) acquired the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda..Fuchs SE (XTRA:FPE3) acquired the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda. on September 1, 2023. Fuchs SE (XTRA:FPE3) completed the acquisition of the remaining 35% stake in Fuchs lubricants SpA from Comercial Pacific Ltda. on September 1, 2023.
Reported Earnings • Jul 30Second quarter 2023 earnings releasedSecond quarter 2023 results: Revenue: €886.0m (up 6.5% from 2Q 2022). Net income: €68.0m (up 12% from 2Q 2022). Profit margin: 7.7% (up from 7.3% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 5.9% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Upcoming Dividend • Apr 27Upcoming dividend of €1.07 per share at 2.9% yieldEligible shareholders must have bought the stock before 04 May 2023. Payment date: 08 May 2023. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.9%. Lower than top quartile of British dividend payers (5.8%). Higher than average of industry peers (2.3%).
Reported Earnings • Mar 09Full year 2022 earnings released: EPS: €1.87 (vs €1.82 in FY 2021)Full year 2022 results: EPS: €1.87 (up from €1.82 in FY 2021). Revenue: €3.41b (up 19% from FY 2021). Net income: €259.0m (up 2.4% from FY 2021). Profit margin: 7.6% (down from 8.8% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 1.5% growth forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 8% per year and the company’s share price has also increased by 8% per year.
お知らせ • Jan 02+ 3 more updatesFuchs Petrolub SE, Annual General Meeting, May 03, 2023Fuchs Petrolub SE, Annual General Meeting, May 03, 2023.
Reported Earnings • Oct 30Third quarter 2022 earnings releasedThird quarter 2022 results: Revenue: €902.0m (up 26% from 3Q 2021). Net income: €70.0m (up 15% from 3Q 2021). Profit margin: 7.8% (down from 8.5% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 8.6% decline forecast for the Chemicals industry in the United Kingdom.
お知らせ • Oct 25Fuchs Petrolub SE to Report Fiscal Year 2022 Results on Mar 08, 2023Fuchs Petrolub SE announced that they will report fiscal year 2022 results on Mar 08, 2023
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment improved over the past weekAfter last week's 65% share price gain to €43.87, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 44% over the past three years.
Valuation Update With 7 Day Price Move • Sep 14Investor sentiment improved over the past weekAfter last week's 60% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 36% over the past three years.
Valuation Update With 7 Day Price Move • Aug 30Investor sentiment improved over the past weekAfter last week's 59% share price gain to €43.87, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 50% over the past three years.
Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improved over the past weekAfter last week's 54% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 49% over the past three years.
Reported Earnings • Aug 01Second quarter 2022 earnings releasedSecond quarter 2022 results: Revenue: €832.0m (up 17% from 2Q 2021). Net income: €61.0m (down 6.2% from 2Q 2021). Profit margin: 7.3% (down from 9.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 4.7% compared to a 20% decline forecast for the industry in the United Kingdom.
Valuation Update With 7 Day Price Move • Jul 27Investor sentiment improved over the past weekAfter last week's 52% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 35% over the past three years.
Valuation Update With 7 Day Price Move • Jul 12Investor sentiment improved over the past weekAfter last week's 63% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €80.44 per share.
Valuation Update With 7 Day Price Move • Jun 27Investor sentiment improved over the past weekAfter last week's 75% share price gain to €43.87, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €84.69 per share.
Valuation Update With 7 Day Price Move • Jun 10Investor sentiment improved over the past weekAfter last week's 50% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 36% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €74.01 per share.
Valuation Update With 7 Day Price Move • May 26Investor sentiment improved over the past weekAfter last week's 59% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 18x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 34% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €77.33 per share.
Valuation Update With 7 Day Price Move • May 06Investor sentiment improved over the past weekAfter last week's 46% share price gain to €43.87, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 33% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €77.38 per share.
Reported Earnings • May 01First quarter 2022 earnings releasedFirst quarter 2022 results: Revenue: €808.0m (up 16% from 1Q 2021). Net income: €67.0m (down 5.6% from 1Q 2021). Profit margin: 8.3% (down from 10% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 6.9% compared to a 16% decline forecast for the industry in the United Kingdom.
Upcoming Dividend • Apr 27Upcoming dividend of €1.03 per shareEligible shareholders must have bought the stock before 04 May 2022. Payment date: 06 May 2022. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 3.4%. Lower than top quartile of British dividend payers (4.6%). Higher than average of industry peers (2.7%).
Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improved over the past weekAfter last week's 32% share price gain to €43.87, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €62.33 per share.
Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 39% share price gain to €43.87, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 24% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €71.38 per share.
Valuation Update With 7 Day Price Move • Mar 01Investor sentiment improved over the past weekAfter last week's 21% share price gain to €43.87, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 19% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €65.29 per share.
Valuation Update With 7 Day Price Move • Feb 14Investor sentiment improved over the past weekAfter last week's 15% share price gain to €43.87, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 21x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 14% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €61.71 per share.
Valuation Update With 7 Day Price Move • Jan 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to €43.87, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 22x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 15% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €60.27 per share.
Reported Earnings • Nov 03Third quarter 2021 earnings released: EPS €0.44The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: €718.0m (up 16% from 3Q 2020). Net income: €61.0m (down 3.2% from 3Q 2020). Profit margin: 8.5% (down from 10% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 2% per year.
Valuation Update With 7 Day Price Move • Oct 12Investor sentiment improved over the past weekAfter last week's 15% share price gain to €43.87, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 24x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 2.4% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €61.82 per share.
Reported Earnings • Aug 01Second quarter 2021 earnings releasedThe company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €714.0m (up 42% from 2Q 2020). Net income: €65.0m (up 132% from 2Q 2020). Profit margin: 9.1% (up from 5.6% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 5% per year.
Reported Earnings • May 04First quarter 2021 earnings releasedThe company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €697.0m (up 13% from 1Q 2020). Net income: €71.0m (up 39% from 1Q 2020). Profit margin: 10% (up from 8.3% in 1Q 2020). The increase in margin was driven by higher revenue.
Upcoming Dividend • Apr 28Upcoming dividend of €0.99 per shareEligible shareholders must have bought the stock before 05 May 2021. Payment date: 07 May 2021. Trailing yield: 2.2%. Lower than top quartile of British dividend payers (4.1%). Higher than average of industry peers (1.6%).
Reported Earnings • Mar 10Full year 2020 earnings released: EPS €1.58 (vs €1.64 in FY 2019)The company reported a soft full year result with weaker earnings and revenues, although profit margins were improved. Full year 2020 results: Revenue: €2.38b (down 7.5% from FY 2019). Net income: €220.0m (down 3.5% from FY 2019). Profit margin: 9.3% (up from 8.9% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Analyst Estimate Surprise Post Earnings • Mar 10Revenue beats expectationsRevenue exceeded analyst estimates by 0.1%. Over the next year, revenue is forecast to grow 8.6% compared to a 9.5% decline forecast for the Chemicals industry in the United Kingdom.
Is New 90 Day High Low • Feb 26New 90-day low: €45.38The company is down 6.0% from its price of €48.16 on 27 November 2020. The British market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €42.92 per share.
Is New 90 Day High Low • Feb 08New 90-day high: €49.44The company is up 6.0% from its price of €46.68 on 10 November 2020. The British market is also up 6.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €44.43 per share.
Is New 90 Day High Low • Nov 11New 90-day high: €47.62The company is up 24% from its price of €38.30 on 13 August 2020. The British market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.96 per share.
Analyst Estimate Surprise Post Earnings • Nov 05Revenue beats expectationsRevenue exceeded analyst estimates by 14%. Over the next year, revenue is forecast to grow 4.2% compared to a 14% decline forecast for the Chemicals industry in the United Kingdom.
Is New 90 Day High Low • Oct 17New 90-day high: €45.98The company is up 20% from its price of €38.16 on 17 July 2020. The British market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €40.29 per share.
Is New 90 Day High Low • Sep 29New 90-day high: €42.62The company is up 19% from its price of €35.72 on 01 July 2020. The British market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €39.66 per share.